First meeting of Empowered Committee for COVID-19 Response held today

Image
ANI General News
Last Updated : Mar 21 2020 | 9:35 PM IST

The first meeting of the Empowered Committee for COVID-19 Response was held on Saturday.

The meeting was co-chaired by Dr. Vinod Paul, Member NITI-Aayog and Professor K. Vijay Raghavan, Principal Scientific Advisor to Government of India.

The Committee was constituted to co-ordinate, amongst science agencies, scientists and regulatory bodies, and take speedy decisions on R & D to implementation related to the SARS-Cov-2 virus and the COVID-19 disease was held on March 21, 2020.

According to an official release, Indian research institutions and organizations are directed for speedy implementation of solutions related to COVID-19.

"National research labs (defined as labs of DBT/DST/CSIR/DRDO/DAE for this directive) are permitted to carry out clinical testing for COVID19 based on self-assessment and willingness to follow established protocols and all applicable reporting regulations as defined by the DHR/ICMR," it said.

The national research labs are permitted to access samples for COVID19 - related research from any government-approved clinical testing site or access clinical samples received by them for testing, subject to ethical approval for such research.

"Results from such research are required to be expeditiously shared in open formats to maximise the impact of research. Clinical care agencies are directed to enrich the open dataset by providing de-identified clinical data," read the release.

"Labs with BSL-3 or BSL-3+ facilities, with DBT/DST/CSIR/DRDO/DAE, are permitted to culture the virus and serve as additional testing and validation sites for research, based on self-assessment of BSL-3 facilities and willingness to follow established protocols as defined by the DHF2/ICMR. They may further share reagents and facilities with other national labs to ensure maximum effort for rapid solutions," the release said.

"Hospitals (Centre, State and private) to cooperate with national labs for clinical sample collection where there is an ethical approval in place, subject to capacity for such work and ability to follow established protocols," it said further.

The total number of positive cases of coronavirus has climbed to 283, said the Union Ministry of Health and Family Welfare on Saturday.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 21 2020 | 9:20 PM IST

Next Story